Eugene

Pfizer and Sangamo Therapeutics, a Richmond, California-based biotechnology company, have partnered to develop a potential gene therapy using zinc-finger-protein transcription factors (ZFP-TFs) to treat amyotrophic lateral sclerosis (ALS) and frontotemporal…

Array BioPharma, a Boulder, Colorado-based biopharmaceutical company developing small-molecule anti-cancer therapies, has granted Aslan Pharmaceuticals, a Singapore-based biotechnology company focused on immunotherapies and targeted agents for Asia-prevalent tumor types, full…

Takeda Pharmaceutical has signed an agreement with Denali Therapeutics, a San Francisco, California-headquartered biotechnology company developing drugs for treating neurodegenerative diseases, to develop and commercialize up to three specified therapeutic…

Teva Pharmaceutical Industries has signed a license agreement with Alder BioPharmaceuticals, a Bothell, Washington-headquartered clinical-stage biopharmaceutical company, to develop, manufacture, and commercialize Alder’s investigational migraine drug, eptinezumab. The agreement resolves…

Pfizer and Berkeley Lights (BLI), an Emeryville, California-headquartered company developing platforms for biopharmaceutical processes, have signed an agreement to accelerate Pfizer’s monoclonal antibody (mAb) discovery and gene-editing workflows by using…

Roche has entered into a strategic, long-term partnership with GE Healthcare to jointly develop and co-market digital clinical-decision support software. The partnership will initially focus on products designed to accelerate…

Sanofi and Regeneron Pharmaceuticals, a Tarrytown, New York-based biopharmaceutical company, have agreed to expand their investment for the clinical development of cemiplimab, a programmed cell death protein 1 antibody for…